Call Options

8 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$5.53 - $7.28 $24,885 - $32,760
-4,500 Reduced 43.27%
5,900 $37,000
Q1 2024

May 15, 2024

BUY
$7.44 - $11.21 $35,712 - $53,808
4,800 Added 85.71%
10,400 $78,000
Q4 2023

Feb 14, 2024

SELL
$6.71 - $10.16 $100,650 - $152,400
-15,000 Reduced 72.82%
5,600 $51,000
Q3 2023

Nov 14, 2023

BUY
$9.35 - $14.32 $48,620 - $74,464
5,200 Added 33.77%
20,600 $208,000
Q2 2023

Aug 14, 2023

SELL
$9.86 - $13.12 $56,202 - $74,784
-5,700 Reduced 27.01%
15,400 $192,000
Q1 2023

May 15, 2023

BUY
$10.23 - $14.76 $67,518 - $97,416
6,600 Added 45.52%
21,100 $246,000
Q4 2022

Feb 14, 2023

SELL
$6.86 - $11.32 $209,916 - $346,392
-30,600 Reduced 67.85%
14,500 $154,000
Q3 2022

Nov 14, 2022

BUY
$9.3 - $18.27 $419,430 - $823,977
45,100 New
45,100 $437,000

Others Institutions Holding HCAT

About Health Catalyst, Inc.


  • Ticker HCAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 54,723,400
  • Market Cap $425M
  • Description
  • Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accura...
More about HCAT
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.